Xu Shen

2.5k total citations
57 papers, 2.0k citations indexed

About

Xu Shen is a scholar working on Molecular Biology, Organic Chemistry and Biotechnology. According to data from OpenAlex, Xu Shen has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 13 papers in Organic Chemistry and 8 papers in Biotechnology. Recurrent topics in Xu Shen's work include Peroxisome Proliferator-Activated Receptors (7 papers), Signaling Pathways in Disease (6 papers) and Retinoids in leukemia and cellular processes (5 papers). Xu Shen is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (7 papers), Signaling Pathways in Disease (6 papers) and Retinoids in leukemia and cellular processes (5 papers). Xu Shen collaborates with scholars based in China, United States and Japan. Xu Shen's co-authors include Hualiang Jiang, Kaixian Chen, Jianhua Shen, Yu Zhang, Tian Liu, Qing Yang, Haitao Zhang, Jian Wang, Lihong Hu and Hexin Xie and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Xu Shen

56 papers receiving 2.0k citations

Peers

Countries citing papers authored by Xu Shen

Since Specialization

Citations

This map shows the geographic impact of Xu Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Shen more than expected).

Fields of papers citing papers by Xu Shen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Shen. The network helps show where Xu Shen may publish in the future.

Co-authorship network of co-authors of Xu Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Xu Shen. A scholar is included among the top collaborators of Xu Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Shen. Xu Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multi-Target Therapeutic Potential of Arctii Fructus Lignans in Diabetes Mellitus and Its Complications: A Mechanistic Review 2025 ·Pharmaceuticals ·(unknown), (unknown), Yulong Hu, (unknown), (unknown), Yuanfang Kong, Xu Shen, Lifeng Zhu, Shao‐Hua Yang, (unknown)	0
2	Discovery and SAR study of hydroxyacetophenone derivatives as potent, non-steroidal farnesoid X receptor (FXR) antagonists 2014 ·Bioorganic & Medicinal Chemistry ·Peng Liu, Xing Xu, Lili Chen, Lei Ma, Xu Shen, Lihong Hu	17
3	Structural Insights into Chitinolytic Enzymes and Inhibition Mechanisms of Selective Inhibitors 2014 ·Current Pharmaceutical Design ·Tian Liu, Lei Chen, Qiang Ma, Xu Shen, Qing Yang	27
4	Development of a new colorimetric assay for lipoxygenase activity 2013 ·Analytical Biochemistry ·Weiqiang Lü, Xue Zhi Zhao, Zhongyu Xu, (unknown), Shien Zou, Xu Shen, Jin Huang	53
5	Latanoprost effectively ameliorates glucose and lipid disorders in db/db and ob/ob mice 2013 ·Diabetologia ·Gaihong Wang, Xing Xu, Xingang Yao, Zhiyuan Zhu, Liang Yu, Lili Chen, Jing Chen, Xu Shen	13
6	Natural products as a gold mine for selective matrix metalloproteinases inhibitors 2012 ·Bioorganic & Medicinal Chemistry ·Liyan Wang, Xi Li, Shoude Zhang, Weiqiang Lü, Sha Liao, Xiaofeng Liu, Lei Shan, Xu Shen, Hualiang Jiang, Weidong Zhang, Jin Huang, Honglin Li	42
7	The Effect of the Potential PhoQ Histidine Kinase Inhibitors on Shigella flexneri Virulence 2011 ·PLoS ONE ·Xia Cai, Jian Zhang, Mingliang Chen, Yang Wu, Xueqing Wang, Jiayu Chen, Junqin Zhang, Xu Shen, Di Qu, Hualiang Jiang	32
8	Molecular Basis of NDM-1, a New Antibiotic Resistance Determinant 2011 ·PLoS ONE ·Zhongjie Liang, Lianchun Li, Yuanyuan Wang, Limin Chen, Xiangqian Kong, Hong Yao, Lefu Lan, Mingyue Zheng, (unknown), Hong Liu, Xu Shen, Cheng Luo, Keqin Kathy Li, Kaixian Chen, Hualiang Jiang	59
9	Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling 2010 ·BMC Pharmacology ·Baohong Jiang, Jing Chen, Lingling Xu, Zhenting Gao, Yanping Deng, Yanhui Wang, Feng Xu, Xu Shen, De‐an Guo	55
10	Structural Determinants of an Insect β-N-Acetyl-d-hexosaminidase Specialized as a Chitinolytic Enzyme 2010 ·Journal of Biological Chemistry ·Tian Liu, Haitao Zhang, Fengyi Liu, Qingyue Wu, Xu Shen, Qing Yang	91
11	Diastereoisomeric macrocyclic polydisulfides from the mangrove Bruguiera gymnorrhiza 2009 ·Phytochemistry ·Xiao‐Ying Huang, Qi Wang, Haili Liu, Yu Zhang, Guorong Xin, Xu Shen, Meiling Dong, Yue‐Wei Guo	30
12	A New Assay Based on Fluorescence Resonance Energy Transfer to Determine the Binding Affinity of Bcl-x_LInhibitors 2008 ·Bioscience Biotechnology and Biochemistry ·Yu Feng, Xu Shen, Kaixian Chen, Hualiang Jiang, Dongxiang Liu	3
13	A new dolabellane diterpenoid from the Hainan soft coralSpongodessp. 2007 ·Natural Product Research ·(unknown), Rui Jia, Xu Shen, Yue‐Wei Guo	10
14	Organocatalytic Enantioselective Cascade Michael–Aldol Condensation Reactions: Efficient Assembly of Densely Functionalized Chiral Cyclopentenes 2007 ·Angewandte Chemie International Edition ·Jian Wang, Hao Li, Hexin Xie, Liansuo Zu, Xu Shen, Wei Wang	91
15	Bcl-xL Forms Two Distinct Homodimers at Non-ionic Detergents: Implications in the Dimerization of Bcl-2 Family Proteins 2007 ·The Journal of Biochemistry ·Feng Yu, (unknown), Xu Shen, Kaixian Chen, Hualiang Jiang, Dongxiang Liu	10
16	Techniques used for the discovery of therapeutic compounds: The case of SARS 2006 ·Drug Discovery Today Technologies ·Shuai Chen, Lili Chen, Kaixian Chen, Xu Shen, Hualiang Jiang	7
17	Characterization and inhibitor discovery of one novel malonyl‐CoA: Acyl carrier protein transacylase (MCAT) from Helicobacter pylori 2006 ·FEBS Letters ·Weizhi Liu, Cong Han, Lihong Hu, Kaixian Chen, Xu Shen, Hualiang Jiang	33
18	Discovering novel chemical inhibitors of human cyclophilin A: Virtual screening, synthesis, and bioassay 2005 ·Bioorganic & Medicinal Chemistry ·Jian Li, Jing Chen, Chunshan Gui, Li Zhang, Yu Qin, Qiang Xu, Jian Zhang, Hong Liu, Xu Shen, Hualiang Jiang	33
19	Ligand‐binding regulation of LXR/RXR and LXR/PPAR heterodimerizations: SPR technology‐based kinetic analysis correlated with molecular dynamics simulation 2005 ·Protein Science ·(unknown), Fei Ye, Chunshan Gui, Hai‐Bin Luo, CAI JIAN-HUA, Jianhua Shen, Kaixian Chen, Xu Shen, Hualiang Jiang	49
20	Structural basis for mRNA Cap-Binding regulation of eukaryotic initiation factor 4E by 4E-binding protein, studied by spectroscopic, X-ray crystal structural, and molecular dynamics simulation methods 2005 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·Koji Tomoo, (unknown), Hiroyuki Fujisaki, (unknown), Xu Shen, Taizo Taniguchi, H. Miyagawa, Kunihiro Kitamura, Kin‐ichiro Miura, Toshimasa Ishida	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact